These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19072538)

  • 1. Conjugation of Kahalalide F with gold nanoparticles to enhance in vitro antitumoral activity.
    Hosta L; Pla-Roca M; Arbiol J; López-Iglesias C; Samitier J; Cruz LJ; Kogan MJ; Albericio F
    Bioconjug Chem; 2009 Jan; 20(1):138-46. PubMed ID: 19072538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convergent approaches for the synthesis of the antitumoral peptide, Kahalalide F. Study of orthogonal protecting groups.
    Gracia C; Isidro-Llobet A; Cruz LJ; Acosta GA; Alvarez M; Cuevas C; Giralt E; Albericio F
    J Org Chem; 2006 Sep; 71(19):7196-204. PubMed ID: 16958512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonendosomal cellular uptake of ligand-free, positively charged gold nanoparticles.
    Taylor U; Klein S; Petersen S; Kues W; Barcikowski S; Rath D
    Cytometry A; 2010 May; 77(5):439-46. PubMed ID: 20104575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completely dispersible PEGylated gold nanoparticles under physiological conditions: modification of gold nanoparticles with precisely controlled PEG-b-polyamine.
    Miyamoto D; Oishi M; Kojima K; Yoshimoto K; Nagasaki Y
    Langmuir; 2008 May; 24(9):5010-7. PubMed ID: 18386943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorimetric enzymatic activity assay based on noncrosslinking aggregation of gold nanoparticles induced by adsorption of substrate peptides.
    Oishi J; Asami Y; Mori T; Kang JH; Niidome T; Katayama Y
    Biomacromolecules; 2008 Sep; 9(9):2301-8. PubMed ID: 18680343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-natural amino acids containing peptide-capped gold nanoparticles for drug delivery application.
    Parween S; Ali A; Chauhan VS
    ACS Appl Mater Interfaces; 2013 Jul; 5(14):6484-93. PubMed ID: 23767970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of kahalalide F synthetic analogues.
    Jiménez JC; López-Macià A; Gracia C; Varón S; Carrascal M; Caba JM; Royo M; Francesch AM; Cuevas C; Giralt E; Albericio F
    J Med Chem; 2008 Aug; 51(16):4920-31. PubMed ID: 18672864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic light scattering as a powerful tool for gold nanoparticle bioconjugation and biomolecular binding studies.
    Jans H; Liu X; Austin L; Maes G; Huo Q
    Anal Chem; 2009 Nov; 81(22):9425-32. PubMed ID: 19803497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-functionalized gold nanoparticles.
    Gibson JD; Khanal BP; Zubarev ER
    J Am Chem Soc; 2007 Sep; 129(37):11653-61. PubMed ID: 17718495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface.
    Cheng Y; Samia AC; Li J; Kenney ME; Resnick A; Burda C
    Langmuir; 2010 Feb; 26(4):2248-55. PubMed ID: 19719162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles.
    Kong T; Zeng J; Wang X; Yang X; Yang J; McQuarrie S; McEwan A; Roa W; Chen J; Xing JZ
    Small; 2008 Sep; 4(9):1537-43. PubMed ID: 18712753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide.
    Guerrero S; Araya E; Fiedler JL; Arias JI; Adura C; Albericio F; Giralt E; Arias JL; Fernández MS; Kogan MJ
    Nanomedicine (Lond); 2010 Aug; 5(6):897-913. PubMed ID: 20735225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional gold nanoparticle-peptide complexes as cell-targeting agents.
    Sun L; Liu D; Wang Z
    Langmuir; 2008 Sep; 24(18):10293-7. PubMed ID: 18715022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Two Approaches for the Attachment of a Drug to Gold Nanoparticles and Their Anticancer Activities.
    Fu Y; Feng Q; Chen Y; Shen Y; Su Q; Zhang Y; Zhou X; Cheng Y
    Mol Pharm; 2016 Sep; 13(9):3308-17. PubMed ID: 27518201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold nanoparticles enhance the anti-leukemia action of a 6-mercaptopurine chemotherapeutic agent.
    Podsiadlo P; Sinani VA; Bahng JH; Kam NW; Lee J; Kotov NA
    Langmuir; 2008 Jan; 24(2):568-74. PubMed ID: 18052300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
    Mandal BB; Kundu SC
    Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The forthcoming applications of gold nanoparticles in drug and gene delivery systems.
    Pissuwan D; Niidome T; Cortie MB
    J Control Release; 2011 Jan; 149(1):65-71. PubMed ID: 20004222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-mediated cell penetration and targeted delivery of gold nanoparticles into lysosomes.
    Dekiwadia CD; Lawrie AC; Fecondo JV
    J Pept Sci; 2012 Aug; 18(8):527-34. PubMed ID: 22764089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural control of peptide-coated gold nanoparticle assemblies by the conformational transition of surface peptides.
    Higuchi M; Ushiba K; Kawaguchi M
    J Colloid Interface Sci; 2007 Apr; 308(2):356-63. PubMed ID: 17270198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold nanoparticle-modified ultramicroelectrode arrays for biosensing: a comparative assessment.
    Orozco J; Jiménez-Jorquera C; Fernández-Sánchez C
    Bioelectrochemistry; 2009 Jun; 75(2):176-81. PubMed ID: 19401273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.